# Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer

> **NCT02072317** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 140 (estimated)

## Conditions studied

- Advanced Gastric Cancer

## Interventions

- **DRUG:** taxel plus raltitrexed
- **DRUG:** taxol

## Key facts

- **NCT ID:** NCT02072317
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2014-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02072317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02072317, "Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02072317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*